Precigen, Inc.
PGEN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001356090
In the last 90 days, Precigen, Inc. insiders filed 1 open-market purchase and 6 sales; 210 institutions reported holding it in 13F filings for Q2 2026, worth $799.4M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Precigen, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 127
- −1 vs. Q2 2024
- Shares held
- 75.4M
- +25.5M (+51.0%) vs. Q2 2024
- Total value
- $71.7M
- −$7.17M (−9.1%) vs. Q2 2024
- New holders
- 16
- 37 more added
- Sold out
- 17
- 32 more reduced
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PGEN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 210 | $799.4M |
| Q1 2026 | 206 | $516.7M |
| Q4 2025 | 179 | $568.5M |
| Q3 2025 | 167 | $366.2M |
| Q2 2025 | 147 | $116.6M |
| Q1 2025 | 138 | $119.3M |
| Q4 2024 | 133 | $84.8M |
| Q3 2024 | 127 | $71.7M |
| Q2 2024 | 130 | $95.9M |
| Q1 2024 | 129 | $89.4M |
| Q4 2023 | 137 | $83.9M |
| Q3 2023 | 138 | $86.0M |
| Q2 2023 | 138 | $66.0M |
| Q1 2023 | 157 | $65.1M |
| Q4 2022 | 161 | $64.3M |
| Q3 2022 | 165 | $265.0M |
| Q2 2022 | 169 | $182.2M |
| Q1 2022 | 173 | $302.8M |
| Q4 2021 | 168 | $529.9M |
| Q3 2021 | 172 | $690.3M |
| Q2 2021 | 150 | $926.2M |
| Q1 2021 | 166 | $978.6M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Precigen, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cetera Investment Advisers | 260,312 | $246.5K | 0.00% | −7,500−2.8% | Reduced |
| LexAurum Advisors, LLC | 274,489 | $260.0K | 0.06% | +33,300+13.8% | Added |
| Fore Capital, LLC | 306,811 | $290.6K | 0.56% | +100,000+48.4% | Added |
| Bank of New York Mellon Corp | 333,952 | $316.3K | 0.00% | −87,836−20.8% | Reduced |
| FMR LLC | 345,204 | $326.9K | 0.00% | +72,033+26.4% | Added |
| MSD Partners, L.P. | 355,000 | $336.2K | 0.21% | 00.0% | Unchanged |
| Sanders Morris Harris LLC | 363,182 | $344.0K | 0.06% | −196,318−35.1% | Reduced |
| Citadel Advisors LLC | 382,999 | $362.7K | 0.00% | −36,757−8.8% | Reduced |
| Goldman Sachs Group Inc | 445,313 | $421.8K | 0.00% | +110,388+33.0% | Added |
| Tang Capital Management LLC | 500,000 | $473.6K | 0.03% | +500,000 | New |
| Nuveen Asset Management, LLC | 534,983 | $506.7K | 0.00% | 00.0% | Unchanged |
| CI Private Wealth, LLC | 614,971 | $582.4K | 0.00% | +614,971 | New |
| GMT Capital Corp | 668,830 | $633.4K | 0.03% | 00.0% | Unchanged |
| ClariVest Asset Management LLC | 492,152 | $777.6K | 0.08% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 884,275 | $837.5K | 0.00% | −194,514−18.0% | Reduced |
| Northern Trust Corp | 1,046,989 | $991.6K | 0.00% | +15,673+1.5% | Added |
| Morgan Stanley | 1,215,350 | $1.15M | 0.00% | +208,046+20.7% | Added |
| D. E. Shaw & Co., Inc. | 1,217,631 | $1.15M | 0.00% | −511,311−29.6% | Reduced |
| Charles Schwab Investment Management Inc | 1,222,850 | $1.16M | 0.00% | +127,467+11.6% | Added |
| Renaissance Technologies LLC | 1,600,190 | $1.52M | 0.00% | +417,500+35.3% | Added |
| State Street Corp | 2,872,064 | $2.72M | 0.00% | +29,253+1.0% | Added |
| Geode Capital Management, LLC | 3,246,508 | $3.08M | 0.00% | +149,829+4.8% | Added |
| Iridian Asset Management LLC | 3,775,960 | $3.58M | 0.77% | +1,706,815+82.5% | Added |
| Vanguard Group Inc | 8,328,141 | $7.89M | 0.00% | +1,568,781+23.2% | Added |
| BlackRock, Inc. | 10,368,497 | $9.82M | 0.00% | +10,368,497 | New |
| Adage Capital Partners GP, L.L.C. | 10,865,405 | $10.3M | 0.02% | +10,865,405 | New |
| Patient Capital Management, LLC | 17,937,694 | $17.0M | 0.83% | −236,964−1.3% | Reduced |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −93−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −155,590−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −76,429−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −70,238−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −56,998−100.0% | Sold out |
| Simplicity Wealth,LLC | 0 | $0 | 0.00% | −39,514−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −30,717−100.0% | Sold out |
| Diversified Trust Co | 0 | $0 | 0.00% | −29,126−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −24,783−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −13,594−100.0% | Sold out |
| Buckingham Strategic Partners | 0 | $0 | 0.00% | −12,186−100.0% | Sold out |
| OMNI 360 Wealth, Inc. | 0 | $0 | 0.00% | −12,186−100.0% | Sold out |
| Gerber Kawasaki Wealth & Investment Management | 0 | $0 | 0.00% | −10,874−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −1,910−100.0% | Sold out |
| GAMMA Investing LLC | 0 | $0 | 0.00% | −204−100.0% | Sold out |
| Innealta Capital, LLC | 0 | $0 | 0.00% | −99−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −78−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |
| Emfo, LLC | – | – | – | – | Not filed |